TimeX Capital Named In-House Investment Bank for Formation Venture Engineering Management (FVEM)

Amprion Announces Initial Close of a $15M Financing to Commercialize Groundbreaking Neurologic Diagnostics

Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine

Formation Venture Engineering Does Well By Doing Good